ストックスクリーナーアプリを入手
3.415
2.71%
-0.095
アフターアワーズ：
3.42
0.005
+0.15%
前日終値:
$3.51
開ける：
$3.56
24時間の取引高:
14,553
Relative Volume:
0.09
時価総額：
$2.58M
収益：
-
当期純損益:
$-8.82M
株価収益率:
-0.00494
EPS:
-691.4213
ネットキャッシュフロー:
$-8.08M
1週間 パフォーマンス:
-1.30%
1か月 パフォーマンス:
+1.94%
6か月 パフォーマンス:
-45.45%
1年 パフォーマンス:
-97.90%
1日の値動き範囲:
$3.415
$3.6999
1週間の範囲:
$3.3319
$3.6999
52週間の値動き範囲:
$2.90
$179.20
Endra Life Sciences Inc Stock (NDRA) Company Profile
名前
Endra Life Sciences Inc
セクター
電話
734-335-0468
住所
3600 GREEN COURT, ANN ARBOR, MI
NDRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
3.415 | 2.58M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
421.47 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
201.10 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
542.65 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.45 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
162.61 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Endra Life Sciences Inc (NDRA) 最新ニュース
ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancem - GuruFocus
ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard | NDRA Stock News - GuruFocus
ENDRA's Revolutionary Liver Imaging Technology Achieves Major Breakthrough in 100+ Patient Study - Stock Titan
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ENDRA Life Sciences Unveils New Business Strategy - TipRanks
Wall Street Zen Upgrades ENDRA Life Sciences (NASDAQ:NDRA) to Hold - Defense World
Ascendiant Capital Maintains Buy Rating on ENDRA Life Sciences (NDRA) | NDRA Stock News - GuruFocus
Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
ENDRA Life Sciences Faces Nasdaq Compliance Challenge - TipRanks
ENDRA Life Sciences: Strategic Shift and Financial Update - TipRanks
ENDRA Life Sciences Provides a Business Update and Reports First - GuruFocus
ENDRA Life Sciences (NDRA) Aims to Revolutionize Metabolic Disease Detection | NDRA Stock News - GuruFocus
ENDRA Life Sciences Q1 2025 Financial Results and Business Update - TradingView
ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Endra Life Sciences reports Q1 EPS ($1.86) vs ($449.58) last year - TipRanks
ENDRA Life Sciences Provides A Business Update And Reports First Quarter 2025 Financial Results - marketscreener.com
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results - Stock Titan
ENDRA Life Sciences (NDRA) to Release Quarterly Earnings on Tuesday - Defense World
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update - The AM Reporter
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest - Defense World
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Highs and Lows in the Market - investchronicle.com
What is ENDRA Life Sciences Inc (NDRA) Stock Return on Shareholders’ Capital? - Sete News
What Are You Thinking About Investing In ENDRA Life Sciences Inc (NASDAQ: NDRA) Stock? - Stocksregister
ENDRA Life Sciences Inc: Navigating Market Fluctuations with a 1.74M Market Cap - investchronicle.com
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
ENDRA Life Sciences Deploys TAEUS Tech to Improve Metabolic Disease Detection - Medical Product Outsourcing
A Guide To The Risks Of Investing In ENDRA Life Sciences Inc (NDRA) - knoxdaily.com
ENDRA Life Sciences (NASDAQ:NDRA) Given New $50.00 Price Target at Ascendiant Capital Markets - Defense World
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ENDRA Life Sciences Stock Gains Market Momentum - Stocks Telegraph
ENDRA Life Sciences Advances TAEUS Liver Device Strategy - TipRanks
ENDRA Life Sciences pivots to metabolic health market - Investing.com
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartz
ENDRA Life Sciences Inc. SEC 10-K Report - TradingView
How ENDRA's AI-Powered Device Could Transform GLP-1 Weight Loss Treatment Monitoring - Stock Titan
ENDRA Slashes Monthly Expenses 37% as TAEUS Liver Device Advances - Stock Titan
ENDRA Life Sciences Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView
ENDRA Life Sciences (NDRA) Projected to Post Earnings on Thursday - Defense World
ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent - Business Wire
ENDRA Life Sciences stock hits 52-week low at $3.89 amid steep decline - Investing.com Canada
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland - ACCESS Newswire
Critical Contrast: ENDRA Life Sciences (NASDAQ:NDRA) vs. Gadsden Properties (OTCMKTS:GADS) - Defense World
ENDRA Life Sciences to Participate at Upcoming Investor Conferences - ACCESS Newswire
ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe - ACCESS Newswire
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue - ACCESS Newswire
Where are the Opportunities in (NDRA) - Stock Traders Daily
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - MSN
Endra Life Sciences Inc (NDRA) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
2.29%
大文字化:
|
ボリューム (24 時間):